Invention Grant
- Patent Title: Application of anaplasma phagocytophilum protein APH1384
-
Application No.: US16321824Application Date: 2017-06-12
-
Publication No.: US10598660B2Publication Date: 2020-03-24
- Inventor: Hua Niu , Meiling He , Shuyan Wu
- Applicant: SOOCHOW UNIVERSITY
- Applicant Address: CN Suzhou
- Assignee: SOOCHOW UNIVERSITY
- Current Assignee: SOOCHOW UNIVERSITY
- Current Assignee Address: CN Suzhou
- Agency: SZDC Law PC
- Priority: CN201710149621 20170314
- International Application: PCT/CN2017/087912 WO 20170612
- International Announcement: WO2018/166079 WO 20180920
- Main IPC: G01N33/554
- IPC: G01N33/554 ; G01N33/569 ; C07K14/29 ; G01N33/561 ; G01N33/68
Abstract:
The present invention relates to use of an Anaplasma phagocytophilum protein APH1384 as diagnostic antigen for granulocytic anaplasmosis. The protein can remedy the drawback of missed detection of an existing diagnostic antigen P44 for granulocytic anaplasmosis, improve sensitivity of detection for granulocytic anaplasmosis, and facilitate rapid and accurate clinical diagnosis of granulocytic anaplasmosis.
Public/Granted literature
- US20190170747A1 THE APPLICATION OF ANAPLASMA PHAGOCYTOPHILUM PROTEIN APH1384 Public/Granted day:2019-06-06
Information query
IPC分类:
